In addition, many researchers have also proposed that SHMT2 overexpression predicts a poor prognosis and promotes progression in various cancers, including bladder cancer, oral cancer, kidney cancer, and lymphoma [29,30,31,32]. This evidence concerns the gene SHMT2 and cancer.